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R E S U M O
Cirurgia Cardíaca Neonatal
INTRODUCTION 
Over the last twenty years neonatal cardiacsurgery has gradually expanded in both
figures and case complexity, complete
corrections for neonates now being achieved
more and more often. 
In Europe, at the present, neonates
represent 16.7 % of all pediatric cardiac
procedures, but this particular patient group
remains difficult to deal with if one considers
the over-all mortality of 17.7 % – around three
times the mortality observed for all pediatric
patients (5.5 %) and also the mean length of
stay in hospital, which is 15.9 days for
neonates and 11 days for all patients (1).
Neonates are of smaller size and less
weight than infants and children, but they also
have immature organs and systems, tolerating
surgical aggressions and particularly
cardiopulmonary bypass poorly. Neonatal
cardiac surgery needs surgical expertise as
much as optimal post-operative care, in units
with dedicated facilities for neonates, and only
with a combination of both can good results be
achieved.
Surgical options for neonates are divided
between palliation or correction of the cardiac
defect and, over the last ten years, the
pressure for early correction now seems totally
justified. However, one should not ignore the
fact that results depend on the experience of
both the center and the surgeon, and that the
case load might play a role here (2). Finally,
immediate results are not all that counts; long-
t e r m
results matter as well, particularly fine
neurological function, which has been shown
to be affected by extended periods of total
circulatory arrest, a method that is still used
for very complex corrections, notably of the
aortic arch (3).
The immediate surgical risk, together with
the expected long-term outcome are both to be
balanced with the possible known sequelae of
the cardiac lesion itself on the heart (volume
or pressure load), on the lungs and pulmonary
circulation (pulmonary artery disease), and on
the baby’s overall development (congestive 
heart failure, cyanosis, etc.) and also the 
impact of the cardiopathy on the baby’s family,
before any decisions concerning treatment
options are made.
It is clear that strong pressure on early
correction seems more than desirable, provided
that benchmarked results are favorable.  
Perioperative care for neonates
• Care prior to the operation;
• Extra-corporeal circulation; 
• Organ protection;
• Post-operative care.
Neonates often need some sort of medical
optimization prior to surgery (4).  For most
elective procedures the operation should be
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conducted only after the first week of life,
when most of the initial neonatal adaptations
to extra-uterine life have taken place.
Most diagnoses are now made non-
invasively by echocardiography. Cardiac
catheterization and angiography are less and
less used in the critically ill neonate, as they
seem to be detrimental, especially for renal
function and the baby’s general condition.
Babies with obstructive lesions to the left
side of the heart, and particularly those with
aortic arch obstruction, need immediate open-
ing of the ductus arteriosus by prostaglandin 
E infusion (0.05-0.5 mcg/kg/m), mechanical
ventilation, inotropic support and diuretics in
order to restore peripheral systemic perfusion,
support the heart, normalize blood gases,
particularly arterial pH and lactate levels.
Surgery for complex left-sided lesions should
wait until the baby has been resuscitated, is
stable and passing urine adequately, has
normal pH and is metabolically corrected; for
most babies this can be accomplished in not
more than 24 to 48 hours. Nutrition, also, is of
paramount importance for any neonate
undergoing surgery, especially in the presence
of congestive heart failure, due to the fact that
body fat and carbohydrate supplies are limited
in neonates and consumption is dramatically
increased by surgical stress. 
For babies with obstructive lesions to the
right side combined with lung hypoperfusion,
ductal opening might be the only way to
perfuse the lungs, reverse cyanosis and tissue
hypoxia and correct acidosis. These babies do
much better off the ventilator – unless they are
very sick – and should immediately be started
on i.v. prostaglandin (PGE). Surgery shall take
place only after adequate resuscitation is
achieved. 
Another group is complex situations such
as TGA and TAPVD, where the problem is
deficient mixing. These patients undergo
emergent atrial septostomy to improve atrial
mixing, improve circulation dynamics and fight
progressive acidosis. 
TAPVD, especially if obstructed, as is the
rule in the neonate presenting with the infra-
cardiac type, combines mixing defect with
obstruction of venous drainage and represents
a genuine surgical emergency. No time should
be wasted trying to optimize these patients,
other than ventilating them and sending them
to surgery straight away.
Cardiopulmonary bypass (CPB) 284
for neonates
Extra-corporeal circulation is poorly
tolerated by neonates, due to the dilution effect
of the priming volume, due to the pro-
inflammatory component of CPB that is
mediated by the interaction between the
foreign surfaces of the circuit and blood,
through complement cascade activation and
neutrophil and platelet mediation (5). Direct
trauma to the blood cells, different flows and a
broad range of temperatures, all contribute to
post-pump syndrome characterized by capillary
leak, pulmonary vascular resistance fluctuation
and tendency to bleed, together with
multiorgan sequelae. Target organs are the
heart, lungs, kidneys and brain, where
ventricular hemorrhage may occur, especially
in prematures. 
Some of these damaging effects may be min-
imized by appropriate CPB policy – small 
priming volumes, the use of heparin-coated
systems, filters on the arterial line,
vasodilatation during bypass with an α-blocker
drug (phenoxybenzamine) (6) and the conduction
of perfusion with high flow (150 ml/kg) and a
low pressure regime, at all costs minimizing
circulatory arrest periods. All these measures
seem to be protective, promoting better tissue
perfusion.  
The alpha-stat policy, which lets pH drift
with hypothermia and cooling, is both safe and
practical in use, although it is still the subject
of debate, as it would in theory restrict
cerebral blood flow at low temperatures and
extremely alkaline pH (7). 
Even then, capillary leak does occur and
extra vascular water tends to accumulate,
particularly in the heart, lungs, brain and
extra-cellular tissue. The shortest bypass times
and the use of an appropriate CPB policy
certainly attenuate capillary leakage. Modified
u l t r a -
filtration (MUF), introduced by the Great 
Ormond Street group, is now used routinely to
remove extra fluid and to promote
hemoconcentration after CPB in children and
specially in neonates (8). Its beneficial effects
have been demonstrated on reduction of total
body water, but also upon myocardial and lung
function, as well as on the coagulation
cascade. It seems that, besides its
hemoconcentration action, some anti-
inflammatory effect might be expected from the
use of MUF, by filtering and removing
inflammation mediators such as interleukins
1.6 and TNF-α, but this has yet to be proved (9,
10). 
Achieving complete hemostasis is important
for any cardiac operation, but it is crucial for
neonates. Careful surgical technique, warming
of the patients (clotting is not normal in
hypothermic babies), adequate heparin
reversal, aprotinin and selected blood
components (FFP and platelets) are routinely
used to achieve hemostasis. It is essential to
remember that bleeding promotes more
bleeding, due to local fibrinolysis, and also
that  tamponade is common in neonates that
are bleeding. Surgical re-exploration should
not be subject to too much thought or
unnecessary delay in neonates.
Table I
Cardiopulmonary bypass protocol and organ
protection for neonates
• Neonatal – Safe Micro oxygenator + mini-circuit – priming
volume < 300 ml
• Priming: CPD blood* – 100 ml + FF plasma – 100 ml +
NS – 100 ml + 20 % albumin – 10 ml + NaHCO3 -1
mEq/kg + mannitol 20 % - 25 ml + aprotinin - 20 000
units/kg + methylprednisolone  30 mg/kg
• Heparin – 300 units/kg for ACTs > 600 sec (check every
30 min)
• Flow  at  37 ºC – 2.8 l/m/m2
• Vasodilatation – phenoxybenzamine 1 mg/kg 
• Reperfusion protection –  20 % mannitol - 1 ml/kg
(unclamping) + Cagl 500 mg (at 36 ºC) 
• Ultrafiltration: Modified ultrafiltration – 700 ml/m2 filtrated
fluid over 15-20 min
* less than 2 days old.
Organ protection
All the systems and organs in the neonate
are at risk during the operation and whenever
using CPB, due to known inflammatory
reactions and, particularly because of
immaturity – the heart, brain and kidneys,
together with the coagulation cascade need
individualized consideration (11). Experience has
indicated that the pre-operative use of steroids
is protective to the cell membranes and,
accordingly, methyl- prednisolone (30 mg/kg)
is given prior to CPB. Aprotinin is claimed to
spare platelets and to have some anti-
inflammatory action and so 10.000 U/kg
aprotinin is used for all cases, as a bolus at the
beginning of the operation. Judicious
hemodilution (20-30 % hematocrit) is
acceptable for both rheology, at low
temperatures, and oxygen transport together
with appropriate pump flows, and 285
pharmacologically induced vasodilatation with
regitine (1 mg/kg) all seem to reduce the
damaging effects of CPB. Short bypass times
and MUF are also critical in minimizing pump
deleterious effects. The heart needs to be
protected from ischemia by both cold and
cardioplegia. The neonatal heart is resistant to
ischemia but it is also sensitive to capillary
leakage and edema accumulation. Moreover,
the immature heart has low energy supplies,
few myocytes and contractile elements and
inefficient calcium removal mechanisms. As a
consequence of all these immature
characteristics, both systolic and dia-stolic
failure are common after surgery, in what
might be  considered a stunning
(ischemia/reperfusion) lesion. Keeping cross-
c l a m p i n g
times as short as possible, using cardioplegia
(crystalloid or blood – 10 ml/kg once only), at
deep hypothermia (17-20 ºC), or every 30 min
if temperature is above 25 ºC and, especially,
giving it by gentle hand injection (infusion
pressure < 30 mmHg), as well as preventing
perfusion pressures above 50 mmHg, at all 
times, are simple protective measures for the
neonatal heart. 
The brain is at risk from emboli related to
CPB, but particularly when circulatory arrest
is used, as is still nowadays the case for most
procedures on the aortic arch. The Boston
Children’s Hospital Circulatory Arrest Study
has shown, as well as acute changes (seizures),
neurodevelopmental abnormalities at one year
of age when long (> 45 m) circulatory arrest
periods were used in neonates, after the arter-
ial switch operation (3). 
The lungs also suffer from transient
compliance deterioration and gas-exchange
dysfunction, due to interstitial edema and Va/Q
changes but, particularly, endothelial
dysfunction due to leukocyte sequestration
leads to insufficient NO production and favors
pulmonary vascular tone fluctuation and, in
some patients, such as neonates or in children
with pulmonary vascular disease, prompts a
pulmonary hypertensive crisis (12).
The incidence of bleeding due to
hematological abnormalities is around 15%,
and  renal and hepatic failure after CPB in
neonates are present in not more than 5 % (13).
Myocardial failure is common after any
cardiac operation. Typically, even patients
doing well show around 40 % decrease in LV
systolic function and usually deteriorate
between 6 and 18 hours after the operation,
due to de-
layed myocardial inflammation in the process
of the ischemia-reperfusion mechanism (14, 15).
The neonatal heart has a small systolic
functional reserve and is much less compliant
than the adult heart. To optimize its function,
moderate volume loads are given (colloids: 5-
10 ml/kg), together with exogenous calcium
gluconate bolus (10-30 mg/kg), as the heart is
both pre-load and calcium dependent.
Inotropes are useful but, as the myocyte
reserve is small, there is no point in insisting
on extreme inotropic support. Dopamine,
dobutamine and adrenaline, in small to
moderate dosages, are usually enough to
optimize cardiac output and adrenaline, in
high dosages and for long enough, will cause
myocardial necrosis. Pharmacological agents
with associated vasodilator effects, such as the286
new generation phosphodiesterase inhibitor
milrinone, are particularly useful for neonates,
as they combine a mild inotropic effect with
peripheral vasodilatation and afterload
reduction, as well as diastolic function
improvement (16). They are named inodilators
and together with dopamine (which can also
have renal effects) are the first line agents
after the operation. Inhaled nitric oxide (NO) is
a pure pulmonary vasodilator that is useful to
control pulmonary vascular tone and to
improve both RV function and pulmonary gas-
exchange (17, 18).  The neonatal heart has a 
limited stroke volume, therefore cardiac output
is highly dependent on heart rate, which
should be kept between 120 and 200 bpm.
Early diagnosis of cardiac dysfunction and
peripheral oxygen delivery deficit is crucial  in
neonates. In our hands, as in others, high
blood lactate levels have proved useful in
predicting patients that will not survive (19), and
particularly for the early detection of any
cardiovascular events; lactate levels above 150
mg/dl correlated with complications, and above
200 mg/dl with mortality in the intensive
treatment unit (ITU). Besides, lactate
correlated well with the need for inotropes and
proved to be more sensitive than pH in
assessing tissue hypoperfusion and hypoxia (20).
The adequacy of surgical correction should be
first verified in the event of sudden
deterioration, as well as the possibility of
compression or  tamponade, which should
always be considered. Cardiac echo at the
bedside and delayed sternal closure are very
useful tools to deal with these problems after
the operation – if in doubt, surgical re-
exploration should be promptly considered.
Renal function is very important after the
operation and urine output should be kept to
not less than 1  ml/kg/h. Transient low urine
output periods are common and might initially
be due to low cardiac output and, in some cases,
to acute renal failure; measures to improve
cardiovascular status are crucial, but if
oliguria persists furosemide, as a perfusion –
0.5 mg/kg/m – is usually very effective. If
response to furosemide is suboptimal and fluid
or potassium accumulation becomes a
problem, peritoneal dialysis should be started
sooner rather than later, to evacuate ascites
and remove both fluid and potassium. There is
also some evidence that peritoneal dialysis will
remove some of the inflammation mediators
active after the operation (21).
Table II
Post-operative care for neonates
• Ventilator settings:
• IPPV, tidal volume 10-15 ml/kg, rate 30/m, Insp time – 
33%, FiO2 . 75
• Sedation:
• Morphine sulfate: 0.1 mg/kg or 0.5 mg/kg in 50 ml D 5%:
1 to 6 ml/h
• Midazolam: 0.1 mg/kg or 3 mg/kg in 50 ml D 5%: 1 to 6 ml/h
• Maintenance fluid:
• Dx 10% 1/4 saline + {KCl 3 mEq + CaGluc 500 mg + MgSO4
0.4 mg} / 100 ml
• Post-op day 1 and 2 – 2.5 ml/kg/h, post-op day 3 and on – 4
ml/kg/h
• Volume loading:
• Ht > 40 % – 5 % albumin/plasma 5-10 ml/kg
• Ht < 40 % - Blood – 5 ml /kg (+ 1 ml/kg CaGluc / 100 ml CPD
colloid)
• Inotropes:
• Dopamine – 2 -10 mcg/kg/m + milrinone 50 mcg/kg load +
0.25-1 mcg/kg/m 
• Dobutamine – 2 to 10 mcg/kg/m
• Adrenaline – 0.05 – 0.5 mcg/kg/m
• Vasodilators:
• Nitroglycerin – 0.5 – 10 mcg/kg/m
• Diuretics:
• Furosemide 1 mg / kg + aminophylline 3 mg/kg + albumin
20 % 1.5 ml /kg  
• Furosemide: 0.1 – 0.5 mg/kg/h, as perfusion
• Renal failure:
• fluid overload and rising potassium (K > 5.5 mEq) 
• Peritoneal dialysis: 20 ml / kg 30 m cycles alternating 
1.5 /4.25 % solutions
• K 6 mEq: 30 % dextrose – 1.5 ml/kg + insulin 0.25 u/kg +
CaGluc 50 mg/kg 
• Pulmonary HT:
• Sedation – fentanyl 1 - 3 mcg/kg/m pancuronium 0.1 mg/kg SOS
• Ventilation – IPPV, PaCO2 30 mmHg, PaO2 >150 mmHg, pH >7.5
Dobutamine 2-10 mcg/kg/m or isoprenaline 0.02 - 0.5 mcg/kg/m
• Inhaled nitric oxide: 10-80 ppm
Neonates that, despite well-conducted
pharmacological efforts, and after a technically
well conducted repair, keep on deteriorating,
with persistent acidosis due to low cardiac
output, or difficult gas exchange due to
pulmonary hypertension or acute lung injury,
should be offered the option of mechanical
circulatory support, particularly by rescue
extracorporeal membrane oxygenation (ECMO).
This may be established electively, after difficult
weaning from bypass (22), or in the ITU, as an
emergency (23). Results have improved and,
currently more than 50% of post-operative
patients rescued by mechanical assistance will
be hospital survivors.
Table III
Managing specific cardiac lesions in the neonate
• Left sided obstructive lesions 
• • Coarctation and interruption of the aortic arch
• • Critical aortic stenosis
• • Hypoplastic left heart complex
• Right sided obstructive lesions 
• • Tetralogy of Fallot & pulmonary atresia – VSD
• • Critical pulmonary stenosis
• • Pulmonary atresia & intact septum
• Parallel circulation & mixing problems
• • Total anomalous pulmonary venous drainage
• • Truncus arteriosus
• • Transposition of great arteries (TGA)
• • Intact septum – simple TGA
• • Complex TGA (VSD, Taussig-Bing)
Most of the conditions that bring neonates
for cardiac surgery are indicated in Table III,
but due to  space constraints we will only
discuss two of the most important –
transposition of the great arteries and
hypoplastic left heart complex.
Transposition of Great Arteries 
TGA is, anatomically, ventriculo-arterial
discordance (pulmonary artery from the left
ventricle and aorta from the right ventricle).
Intact interventricular septum, patent ductus
and an ASD or patent foramen ovale may be
present in “simple” TGA cases; a VSD may
also be present in around 20 % of cases and
VSD plus aortic arch obstruction occur in
10 % of cases of ‘‘complex’’ TGA and the
Taussig-Bing anomaly (double outlet right
ventricle plus sub-pulmonary VSD). The
coronary anatomy pattern may be abnormal,
particularly in the complex forms of TGA.
Diagnosis is most commonly by echo, which
will identify the intracardiac anatomy as well 287
as the coronary artery origin, but cardiac
angiography may be performed, to elucidate
the coronary pattern and the arch anatomy, this
being done at the time of balloon atrial
septostomy. 
Presentation in the neonate is by cyanosis
and sometimes by acidosis, due to poor blood
mixing, as circulation is in parallel. Immediate
resuscitation is crucial and measures to
improve blood mixing are needed and include
balloon septostomy and ductus re-opening by
prostaglandins. In some babies, particularly in
the presence of coarctation, prostaglandins are
used to open the ductus and to improve mix-
ing, but also to promote distal body perfusion,
favoring diuresis and reversing acidosis.
The arterial switch operation in babies with
“simple” TGA should be done electively
during the first two weeks of life; patients on
prostaglandins for associated coarctation or
obstruction of the aortic arch are operated
during the first days of life, while babies with
TGA – VSD may be operated during the first
three months of life, provided their clinical
condition is good. 
Treatment by the arterial switch operation
is now standard in the neonatal period and 
represents 19.3 % of the neonatal surgical case
load registered  throughout Europe, where
mortality of 10 % for “simple” TGA and over
15 % for “complex” TGA was observed in
2002. Some aspects of surgical management
still merit discussion:
• Late presentation
Surgical management is still a matter of
discussion for “simple” TGA presenting late
(beyond the first month of life), when
pulmonary vascular resistance and pulmonary
arter-ial pressure have dropped to normal
levels. Left ventricle mass is known to involute
rap-idly after birth in babies with “simple”
transposition, and in the absence of a
persistent large ductus, VSD or left ventricular
outflow obstruction, but the LV also
hypertrophies rap-idly, in response to any
pressure load main-
tained for as little as two weeks, a capacity
that is soon lost with age (24). The question is
how safe it is to offer a baby presenting beyond
one month of life the switch operation, since it
has been shown that operative risk increases
with age, from the first week on (25).  The
extreme position, accepted by very
experienced groups, is to offer the switch
procedure to any baby with “simple”
transposition and intact septum, presenting
during the first two months of life, knowing
that some will have a stormy post-operative
period and will eventually need  to be
supported on ECMO, for some time after the
operation (13). After the first month of life it
seems prudent to individualize the indications,
by assessing LV mass and shape, and to offer a
staged procedure – PA banding plus a 4 mm
PTFE shunt, for a 7 to 10-day LV retraining
period – followed immediately by the switch,
whenever LV capacity is in doubt (26). 
• Surgical technique:
The standard procedure at the moment is as
follows (27): The operation is performed through
a median sternotomy, pericardium is harvested
and left untreated, full mobilization of the
aorta, aortic arch and ductus are achieved,
followed by pulmonary artery branch
mobilization, well into the lung hilum. We now
conduct the operation on hypothermic
cardiopulmonary bypass (18 ºC) and use a
short period of circulatory arrest, only for ASD
closure, at the beginning of the operation. The
ductus is divided between ligatures, the aorta
is cross-clamped and crystalloid cardioplegia
(10 ml/kg) is given only once, through the
aortic root. The aorta and pulmonary artery are
transected above the commissures and the
coronary anatomy is in-spected – dual origin is
treated by excision of the coronary buttons,
with a 2 mm margin of aortic tissue and little
mobilization of the arter-ies, and transfer to
neo-aorta openings, using the trap-door
technique, to reduce tension and distortion.
The Lecompte maneuver is used in virtually
all cases, except where vessels are side by
side, and a direct arch to neoaorta anastomosis
is constructed using running 
monofilament suture. The author has used, over
the years, a small pericardial patch anteriorly
to accommodate any (aorta / pulmonary artery)
diameter differences and to reduce tension on
the coronary anastomosis. This procedure has
proved to be both useful and safe (28). 
Still with the aorta clamped, the back wall
of the neo-pulmonary artery is reconstructed,
using a rectangular or trouser-shaped
pericardial patch and  reabsorbable suture,
filling in the coronary excision defects and,
particularly, releasing tension from the
coronary anastomosis. The anterior part of the288
reconstruction is performed with the heart
already beating. Weaning from bypass is
usually uneventful, on a small dose of
dopamine and milrinone; hemostasis has to be
precise. The sternum is left open,
prophylactically, for 48 hours, the chest being
closed with a PTFE pericardial membrane.
This protocol of elective delayed sternal
closure has been shown to be safe and
complication-free. 
In cases where the aortic arch needs to be
addressed (for coarctation or interruption) – in
the presence of VSD or the Taussig-Bing
anomaly – one-stage correction seems to be the
safer approach now (29). In these cases the arch
is addressed first and repaired during a period
of circulatory arrest; however, it has been
possible, over the last few years, to correct the
arch anatomy by an ingenious cannulation of
the innominate artery, without the need for
circulatory arrest (30). The operation then follows
routinely after the arch repair.
• Results 
Results of the switch operation have
improved over the years, but the excellent
figures produced by a few centers, with
mortality below 1%, for “simple” TGA (13) seem
difficult to reproduce, if one considers overall
European figures in which operative mortality
is 3.4 % and 30-day mortality is 10.2 % just
for simple TGA (1). Besides, results vary from
center to center and mortality risk factors have
long been identified (25), with results being
worse with reduced center experience and the
“complex” TGA and Taussig-Bing group, in
which mortality ranged from 7 % in selected
series (31) to more than 15 % (only for TGA
with VSD) when unselected centers are
considered as a whole (1).
Late results have been satisfactory, with
good growth of the anastomosis, especially of
the neo-aorta and of the coronaries, although a
few patients will show some dilatation of the
aortic root and aortic incompetence (around
10 %, especially if a previous band had been
on). Dilatation of the neo-aorta is more
suggestive of  normal growth, as expected for a
normal pulmonary artery, than of pathological
enlargement, as was shown by Karl in an
elegant comparative study in 62 patients (13).
Problems related to supravalvular pulmonary
stenosis are now rare and usually related to
tension on the anastomosis, or to failure to use
fresh pericardium for RVOT reconstruction.
Some patients will also show silent
perfusion defects on myocardium scintigraphy,
independent of contractility changes at rest or
even on exercise, which do not seem to affect
physical performance or survival (32).  
Finally, neurocognitive development has
been studied in a group of babies after
neonatal switch in Boston, for whom
circulatory arrest or low flow were used. The
study showed that at least 25 % of the babies
suffered acutely from either seizures or EEG
changes (33) and showed subnormal
neurocognitive development after the operation
at one and four years  of age (3). This has led
us, like many others, to change our bypass
policy from circulatory arrest to hypothermic
full flow bypass.
Hypoplastic left heart complex (HLHC)
HLHC represents a wide spectrum of
defects, comprising around 6.2 % of all
registered neonatal surgical cases (1). Typically
these neonates present acutely with a
combination of restricted systemic blood flow
(outflow obstruction, at any level) and
excessive pulmonary blood flow.  Anatomy is
varied but the left side of the heart is smallish
to hypoplastic, according to Leung’s definition
criteria (34) of ascending aorta < 5 mm, mitral
valve < 9 mm, and LV inlet < 2.5 mm). An
ASD and ductal patency are critical for
survival and coarctation is commonly present.
Diagnosis is usually pre-natal but will be
easily done after birth; cardiac catheterization
is now used only exceptionally, and may even
be considered detrimental. Defining the
anatomy, and also assessing right ventricular
function and excluding significant tricuspid
regurgitation, are essential to diagnosis. 
After the diagnosis is established the baby
should be kept on i.v. prostaglandins, to keep
the ductus open, and be allowed to breathe
room air with no added oxygen, in order to lim-
it lung flow, by maintaining lung vascular 
tone. Resuscitative measures, inotropes and
ventilation should be on immediate stand-by,
but only used if really needed, as babies
should be operated electively, in good general
condition, and never as a critical emergency. 
Physiological balance seems very important
here, as circulation is in parallel and the
objectives are to balance pulmonary/systemic
resistance and flows and to support the
function of the single ventricle (35). Controlling
pulmonary vascular resistance is paramount, as
lung overflow will lead to systemic 289
hypoperfusion and metabolic acidosis.
Monitoring should include arterial saturation
and mixed venous 
saturation, ideally in the range of 75 % and
55 % respectively, and  blood lactate, both
being very sensitive indicators of ideal oxygen
delivery.  
The possibilities for HLHC are neonatal
cardiac transplantation, which is not a realistic
option, due to the lack of suitable donors (36),
and the Norwood staged procedure. As
designed by Norwood (37), the objectives of
surgery are to create an unobstructed pathway
between the right ventricle (systemic chamber)
and the systemic circulation (performing full
arch reconstruction), to relieve any inlet
obstruction between the pulmonary veins and
the systemic AV valve (creating an
unrestrictive ASD) and to perfuse the lungs by
a controllable, non-
excessive blood flow source (modified BT shunt
or RV to pulmonary artery shunt). All these
first stage procedures will lead optimally to a
Glenn shunt (second stage) at 6 months and
ultimately to a full Fontan procedure (third
stage) at 2-3 years of age. 
• Surgical technique
The first stage Norwood operation is
performed by median sternotomy, cannulation
of the pulmonary artery and right atrium, on
cardiopulmonary bypass at 18 ºC, using
circulatory arrest for the shortest time possible,
only to reconstruct the aortic arch. Repair has
recently been achieved without the need for
total circulatory arrest, by perfusing through
the distal BT shunt (38). 
During the cooling period, full mobilization
of the aortic arch, PA branches, ductus and
descending aorta is performed; a PTFE shunt
(3.5 mm) is then connected to the innominate
artery, and will later be anastomosed to the
right pulmonary artery. Under cardioplegic
arrest (single injection, through the arterial
cannula), the ductus is divided, the arch is
incised retrogradely and the pulmonary trunk
is sectioned above the commissures. The aortic
arch is then reconstructed with a composite
patch of pulmonary homograft, taking care not
to distort the aortic root and the coronary
origins and not to leave any residual
obstruction, allowing for future growth (39). The
author has, on a few occasions and whenever
the ascending aorta is very small, used a
complete homograft tube (complete section of a
PA branch) to connect the transected PA to the
inferior area of the aortic arch, this makes the
repair easier and does not compromise
coronary geometry. Pulmonary bifurcation is
closed next with a ho-mograft patch and the
proximal end of the BT shunt is then
completed. 
Recently, another alternative has been
developed for the pulmonary blood flow
source, by  construction, instead of the
traditional BT shunt: a 5 mm PTFE conduit
between the right ventricular infundibulum
and the pulmonary artery bifurcation (Sano
modification – cited 
in (51)). This modification seems to have several
advantages: more uniform pulmonary flow
distribution, less pulmonary artery distortion,
and particularly easier postoperative care, as
pulmonary flow is only systolic, does not create
aortic run-off and myocardial ischemia and is
not mainly dependent on fluctuations in
pulmonary vascular resistance. 
Weaning off perfusion is tried on a
combination of dopamine and milrinone,
aiming at arterial saturations of 75% and
systolic arterial pressures of 50-60 mmHg; the
sternum is left open for 48 hours. 
• Post-operative care
The critical aspect of the Norwood
procedure is the postoperative period (40), as
both circulations will be supported in parallel
by a right ventricle ejecting through a BT
shunt into the lungs  and through the aortic
arch to the general circulation. Balancing the
flows is crit-ical: complete blood mixing
should be achieved at atrial level, but
resistance through the systemic and pulmonary
networks will dictate the relative flows: too
much pulmonary flow  (due to an excessive BT
shunt or to inappropriate pulmonary
vasodilatation) will produce high oxygen
saturations, but will create coronary run-off,
reduce systemic flow and generate ominous
acidosis and high lactate levels. The much
better tolerated lung hypoperfusion will lead to
high systemic flow rates but, if crit-
ical, as when the BT shunt thromboses, will
cause unacceptably low saturations and
acidosis, prompting urgent shunt revision. 
Monitoring after the operation should
include arterial and “mixed” venous
saturations, as the A-V oxygen difference
correlates best with oxygen delivery, and blood
lactate levels, which indicate the level of290
tissue perfusion (41). 
Different scenarios are possible in the 
failing Norwood, as indicated in Table IV, and
immediate action has to be taken if survival is
to be expected.
• Results
The results with the Norwood operation for
hypoplastic left heart complex, as for other
forms of univentricular heart, have improved
over the last ten years, with selected centers
producing excellent figures, with a mortality of
20% (13). Overall European figures still show
operative mortality of 31.7% and in-hospital
mortality of 45.1% (1). This high initial
mortality will be increased by deaths related to
the following stages in preparation for the
Fontan procedure, making survival, at the end
of the third stage, unlikely for more than 50%
of all patients. Some of these patients, at any
stage, may be shifted to the transplantation
option. Results with cardiac transplantation for
children operated below one year of age are
fair, with a survival of 79.3 % at one month,
69.3 % at one year and 60 % at 5 years (36). 
Currently, the Norwood procedure is being
applied to different anatomical forms of
univentricular heart, some with sub-aortic
Table IV
Postoperative protocol for the Norwood
procedure
• Monitoring
• standard + blood lactate + Venous SAT (55%) + Art SAT (≅75%)
• Ventilation
• IPPV – FiO2 21% Tidal volume 20 ml/kg to keep PCO2 40 mmHg
• Sedation
• Fentanyl 10 – 20 mcg/kg/h + pancuronium 0.1 mg/kg
• Inotropes
• Dopamine – 2-10 mcg/kg/m + MILRINONE 50 mcg/kg load +
0.25-1 mcg/kg/m 
• Dobutamine – 2 to 10 mcg/kg/m
• Hypocoagulation
• Heparin 10 units/kg/h (try not to give platelets)
Typical Post-op Problems
• Arterial SAT > 80 %, increased A-V difference, raising blood
lactate
• • exclude aortic arch obstruction
• • exclude myocardial ischemia & dysfunction
• • increase inotropes, increase PVR (high CO2, low FiO2)
• • excessive shunt – shunt revision
• • ECMO?
• Arterial  SAT < 40 %, A-V difference constant 
• • normal lactate: decrease PVR (pH >7.5, high FiO2, 
low CO2); NO
• • raising lactate:  Heparin + shunt revision
• Normal A-V difference & SATs, but rising lactates: risk of
sudden death – ECMO?
obstruction. Mortality has been related to
different pre-operative factors, such as
anatomic diagnosis, aortic atresia, additional
defects, low birth weight and prematurity
(< 2.5 kg) and genetic syndromes, among
others (42-49). 
Sudden death during the first year after the
first stage Norwood still occurs, at the rate of
4 % (50) – residual lesions, coronary
insufficiency, arrhythmias and shunt occlusion
are all possible causes, but systemic outflow
tract obstruction may also be implicated. A
recent single institution study evaluated 158
patients who underwent the Norwood
procedure for different forms of univentricular
heart and revealed similar mortality rates for
babies with hypoplastic left heart variants and
other forms of univentricular hearts with
associated systemic outflow obstruction. This
study was unable to show any differences in
mortality related to anatomy, but did
demonstrate that the presence of additional
cardiac or extra-cardiac anomalies was a
predictor of  poor outcome (51).
CONCLUSIONS
Neonatal cardiac surgery has experienced 
a tremendous development over the last 10 
years, total correction becoming possible today
for virtually any defect, from simple tetralogy
to transposition of great arteries and truncus
arteriosus. 
Some defects are still difficult to deal with,
as are complex single ventricles, for which
results have improved recently. 
Technical refinements in surgery,
improvements in both perfusion and
anesthesia, notably neurological protection,
and the specialized care of dedicated neonatal
units have all contributed to this level of
excellence, and to the fact that the focus has
now shifted more to the normal development of
these future adults, to their quality of life and
to their long-term survival. 
In neonatal cardiac surgery, as in many
other areas in life, if we wish to go much
further we must step back, back into the
maternal womb, to act on the fetus, possibly by
modifying its faulty hemodynamics, which fetal
echocardiography can now identify so early,
and to promote normal great vessel and
ventricle chamber growth. By doing so, how
many single ventricle defects (still the major
problem we face nowadays) would be gained
for biventricular corrections? The future will 291
show.
We wish to thank Dr. Graça Nogueira for
reviewing the manuscript.
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